medline.ch Onkologie Respirationstrakt

conid:1880
-kaloNeDinamik-------------------------------------------jo
-session-------------------------------------------Array
(
    [ID_S] => IP: 100.24.115.215; DATE: 2022/05/18/ 12:09:31
    [tip] => 2
    [contentType] => db
    [ses_userid] => 2
    [thisMode] => 
    [level_0] => 2
    [level_1] => 15
    [level_2] => 4
    [level_3] => 0
    [level_4] => 0
    [level] => 2
    [nodetype] => 2
    [node_family_id] => 0
    [monitor] => content
    [id_contentit_from_php_file] => 1880
    [uniqueid] => 20220518120931100241152155870
    [lang] => Lng1
    [contentId] => 1880
    [browser] => IE
    [clas_css] => 0
    [level_p] => 2
    [lng] => Lng1
    [nodetype_ci] => -1
    [usr] => 0
    [vazhdopunen] => po
    [search_for] => ("respiratory tract neoplasms"[Majr] OR (("neoplasm"[ti] OR neoplasms[ti] OR cancer[ti] OR carcinoma[ti] OR tumor[ti] OR tumour[ti] OR "secondary"[subheading:majr]) AND (lung[ti] OR pulmonary[ti] OR bronchial[ti] OR pleural[ti]))  AND ("practice guideline" OR systematic[sb] OR "clinical trials"[mesh] OR "meta analysis"[pt] OR "epidemiologic studies"[mesh] OR randomi* OR "meta analysis" OR "evidence based" OR placebo* OR "single blind" OR "double blind" OR "control group" OR "triple blind" OR study[ti] OR studies[ti] OR trial[ti] OR trials[ti] OR consensus OR placebo OR review[pt] OR "sensitivity and specificity"[MeSH Terms] OR diagnos*[Ti] OR diagnosis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR diagnosis,differential[MeSH:noexp] OR diagnosis[Subheading:noexp] OR accuracy[Title/Abstract] OR "predictive value"[Title/Abstract]) AND (english[language] OR german[language] OR french[language] OR italian[language] OR spanish[language]) NOT veterinary[subheading]
)

medline.ch

En | De

Impressum | Feedback

Sie sind hier: Onkologie » Respirationstrakt

18. Mai 2022

Kardiovaskuläre Erkrankungen

Muskuloskelettale Erkrankungen

Gynäkologische Tumoren

Schrift:

Seite 1 von 6265


	Artikel 1 - 20 / 125299

	AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations. J Clin Oncol Lu S, Dong X, Jian H, Chen J, Chen G, Sun Y, Ji Y, Wang Z, Shi J, Lu J, Chen S, Lv D, Zhang G, Liu C, Li J, Yu X, Lin Z, Yu Z, Wang Z, Cui J, Xu X, Fang J, Feng J, Xu Z, Ma R, Hu J, Yang N, Zhou X, Wu X, Hu C, Zhang Z, Lu Y, Hu Y, Jiang L, Wang Q, Guo R, Zhou J, Li B, Hu C, Tong W, Zhang H, Ma L, Chen Y, Jie Z, Yao Y, Zhang L, Jie W, Li W, Xiong J, Ye X, Duan J, Yang H, Sun M, Sun C, Wei H, Li C, Ali SM, Miller VA, Wu Q. PMID: 35580297 [PubMed - as supplied by publisher]
	Delayed visit and treatment of lung cancer during the coronavirus disease 2019 pandemic in Japan: a retrospective study. J Int Med Res Terashima T, Tsutsumi A, Iwami E, Kuroda A, Nakajima T, Eguchi K. PMID: 35579175 [PubMed - in process]
	Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross-sectional study. Thorac Cancer Zhang B, Li X, Ma Z, Zhang S, Song X, Gao H, Gong L, Hu Y, Wang M, Jiang D, Zhang C, Yuan X, Cao B, Zhang P, Nie L, Zhang Y, Chen X, Han L, Wei W, Shi Y. PMID: 35579111 [PubMed - as supplied by publisher]
	Effect of Family Participatory Nursing Model Based on WeChat Platform on Psychological Elasticity and Quality of Life of Patients with Lung Cancer. Biomed Res Int Li L, Xu F, Ye J. PMID: 35578722 [PubMed - in process]
	TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice. Oncogene Hamad SH, Montgomery SA, Simon JM, Bowman BM, Spainhower KB, Murphy RM, Knudsen ES, Fenton SE, Randell SH, Holt JR, Hayes DN, Witkiewicz AK, Oliver TG, Major MB, Weissman BE. PMID: 35577980 [PubMed - as supplied by publisher]
	Exposure of the Heart in Lung Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2013 to 2020. Radiother Oncol Kearney, Keys M, Faivre-Finn C, Wang Z, Aznar MC, Duane F. PMID: 35577022 [PubMed - as supplied by publisher]
	Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study. Lancet Oncol Cho BC, Abreu DR, Hussein M, Cobo M, Patel AJ, Secen N, Lee KH, Massuti B, Hiret S, Yang JCH, Barlesi F, Lee DH, Ares LP, Hsieh RW, Patil NS, Twomey P, Yang X, Meng R, Johnson ML. PMID: 35576957 [PubMed - as supplied by publisher]
	Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y, CAPSTONE-1 Study Group.. PMID: 35576956 [PubMed - as supplied by publisher]
	Meta-analysis Dietary glycemic index, glycemic load intake, and risk for lung cancer: A meta-analysis of observational studies. Nutrition Zhu L, Shu Y, Liu C, Zhu Y, Xiao Y, Ran J, Zhang C. PMID: 35576876 [PubMed - as supplied by publisher]
	Artificial intelligence-powered programmed death ligandÂ 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response. Eur J Cancer Choi S, Cho SI, Ma M, Park S, Pereira S, Aum BJ, Shin S, Paeng K, Yoo D, Jung W, Ock CY, Lee SH, Choi YL, Chung JH, Mok TS, Kim H, Kim S. PMID: 35576849 [PubMed - as supplied by publisher]
	Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer. Bratisl Lek Listy Iriagac Y, Cavdar E, Karaboyun K, Avci O, Alan O, Taskaynatan H, Celikkol A, Kara SP, Erdal B, Seber ES. PMID: 35576541 [PubMed - in process]
	Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial). J Clin Oncol Provencio M, Serna-Blasco R, Nadal E, Insa A, García-Campelo MR, Casal Rubio J, Dómine M, Majem M, Rodríguez-Abreu D, Martínez-Martí A, De Castro Carpeño J, Cobo M, López Vivanco G, Del Barco E, Bernabé Caro R, Viñolas N, Barneto Aranda I, Viteri S, Pereira E, Royuela A, Calvo V, Martín-López J, García-García F, Casarrubios M, Franco F, Sánchez-Herrero E, Massuti B, Cruz-Bermúdez A, Romero A. PMID: 35576508 [PubMed - as supplied by publisher]
	Serum transfer RNA-derived fragment tRF-31-79MP9P9NH57SD acts as a novel diagnostic biomarker for non-small cell lung cancer. J Clin Lab Anal Li J, Cao C, Fang L, Yu W. PMID: 35576497 [PubMed - as supplied by publisher]
	Prediction of Survival Time in Advanced Lung Cancer: A Retrospective Study in Home-Based Palliative Care Unit. Am J Hosp Palliat Care Cui J, Tan L, Fang P, An Z, Du J, Yu L. PMID: 35576493 [PubMed - as supplied by publisher]
	Study on the effect of postoperative intensive pain management in patients with lung cancer surgery. Minerva Surg Chen H, Zhong Y, Wang C, Liu Y. PMID: 35575671 [PubMed - as supplied by publisher]
	Advances in the Study of Circadian Genes in Non-Small Cell Lung Cancer. Integr Cancer Ther Zhang H, Liu R, Zhang B, Huo H, Song Z. PMID: 35575281 [PubMed - in process]
	Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety, and quality of life. Curr Med Res Opin Korde R, Veluswamy R, Barnes G. PMID: 35575164 [PubMed - as supplied by publisher]
	A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer. Acta Oncol Sibille A, Bustin F, Carestia L, Catala G, Compère C, Cuppens K, Colinet B, Coulon S, De Brucker N, Decoster L, Decoster L, Demedts I, Derijcke S, Deschepper K, Galdermans D, Janssens A, Ocak S, Oyen C, Pat K, Pieters T, Pruniau V, Surmont V, Vandekeere S, Vansteenkiste J. PMID: 35574825 [PubMed - as supplied by publisher]
	Association Between Diabetes Risk Reduction Diet and Lung Cancer Risk in 98,159 Participants: Results From a Prospective Study. Front Oncol Zhang Y, Zhong G, Zhu M, Chen L, Wan H, Luo F. PMID: 35574372 [PubMed]
	MR-Guided Microwave Ablation for Lung Malignant Tumor: A Single Center Prospective Study. Front Oncol Lin R, Fang Y, Chen J, Lin Q, Chen J, Yan Y, Chen J, Lin Z. PMID: 35574351 [PubMed]

Artikel 1 - 20 / 125299

Seite 1 von 6265

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung